Navigation Links
Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients

few as only one or no transfusions in the year prior to Soliris treatment."

For the full abstracts of these presentations, please visit the European Hematology Association Web site at http://congress.ehaweb.org/12th.

About PNH

PNH is an acquired genetic blood disorder defined by hemolysis, in which patients' red blood cells are destroyed by complement, a component of the body's immune system. Hemolysis can cause one or more of the following symptoms in patients with PNH: severe anemia, disabling fatigue, recurrent pain, shortness of breath, pulmonary hypertension, intermittent episodes of dark colored urine (hemoglobinuria), kidney disease, impaired quality of life and blood clots (thromboses).(4)(5)

PNH affects an estimated 8,000 to 10,000 people in North America and Europe.(6) PNH often strikes people in the prime of their lives, with an average age of onset in the early 30's.(7) Ten percent of all patients first develop symptoms at 21 years of age or younger.(5) PNH develops without warning and can occur in men and women of all races, backgrounds and ages. PNH often goes unrecognized, with delays in diagnosis often ranging from one to more than 10 years.(8) The estimated median survival for PNH patients is between 10 and 15 years from the time of diagnosis.(6)(8)

PNH has been identified more commonly among patients with disorders of the bone marrow, including aplastic anemia (AA) and myelodysplastic syndrome (MDS).(9)(10)(11)(12) In patients with thrombosis of unknown origin, PNH may be an underlying cause.(5)(13)

There are currently no therapies available in Europe specifically for the treatment of PNH. PNH treatment has been limited to symptom management through periodic blood transfusions, non-specific immunosuppressive therapy and, infrequently, bone marrow transplantations - a procedure that carries considerable mortality risk.(5)(13)

About Soliris
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
(Date:7/27/2015)... PITTSBURGH , July 27, 2015  Mylan N.V. (NASDAQ: ... extraordinary general meeting of shareholders in connection with its proposed ... at the Okura Hotel Amsterdam on Friday, Aug. 28, 2015 ... Among other agenda items at the extraordinary general meeting, Mylan ... 2:107a of the Dutch Civil Code, of the acquisition of ...
(Date:7/27/2015)... 27, 2015  The fairness of the proposed acquisition ... Jude Medical ("St. Jude") is the subject of an ... rights law firm.  The investigation is focusing on possible ... by the Board of Directors of THOR for agreeing ... 2015, the Company announced it had reached a definitive ...
(Date:7/27/2015)... 27, 2015  Array BioPharma Inc. (Nasdaq: ... the fourth quarter and full year of ... to discuss those results on Monday, August ... will lead the call.  Date:Monday, ... 507-2598Pass Code: 68380312 Webcast, including Replay and ...
Breaking Medicine Technology:Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 2Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 3Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 4Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 5Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 6Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 8Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 9Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 10WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders 2
(Date:7/28/2015)... , ... July 28, 2015 , ... A new study ... Easy Fibromyalgia, Study Says " sheds light on a possible new treatment option for ... two months of regular HBOT sessions, at least five per week, patients experienced a ...
(Date:7/28/2015)... ... 2015 , ... There has been much discussion in Washington, D.C. ... often overlooked is the over 740,000 miles of municipal sewer lines designed ... facilities. According to the American Society of Civil Engineers , the average age ...
(Date:7/28/2015)... ... July 28, 2015 , ... Please join us for the 5th Annual Step ... Center located at Gary Avenue and Lies Road in Carol Stream. All are welcome. ... awareness, and provide education and help to support individuals and families affected by a brain ...
(Date:7/28/2015)... AURORA, Colo. (PRWEB) , ... July 28, 2015 ... ... education provider to offer online RN to BSN cohorts for Geisinger ... The education partnership provides GHS diploma and associate degree prepared nurses with access ...
(Date:7/28/2015)... ... , ... Scientel is thrilled to announce that they been accepted ... McHenry Convention Center in San Jose, Ca. Scientel will be participating as a Silver ... and the industry’s first polymorphic database will address the critical need of efficiently storing ...
Breaking Medicine News(10 mins):Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 3Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 2Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 3Health News:American Sentinel University Selected to Provide Online RN to BSN Cohorts to Geisinger Health System 4Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 2Health News:Scientel Selected to Present at 2015 NoSQLNow! Conference, San Jose August 18-20 3
... and Amortization Increased ... 3.85% and 2.96%, Respectively, MEXICO CITY, ... "the Group"), one of the leading Mexican,distributors of pharmaceutical products, ... other products,announces its consolidated financial and operating results for the ...
... WASHINGTON, Feb. 26 The following is a,statement ... Tobacco-Free,Kids:, All Nebraska workplaces, including restaurants, bars ... 2009, thanks to,legislation overwhelmingly approved by the Legislature ... Dave Heineman. Governor Heineman and the,Legislature have delivered ...
... Schnitzer West announced today,that one of the country,s most ... in The Shops at The Bravern in downtown Bellevue ... meet the needs of approximately 2,300,Microsoft employees who will ... beginning this fall., DavidBartonGym will offer Barton,s world ...
... Over 200,of MemorialCare,s top leaders will participate in a ... for Humanity of Orange County. The,home will be renovated ... palsy and is confined to a wheelchair. Halls will ... be given a "makeover" with,upgrades throughout., (Photo: ...
... designed to enhance patient acceptance and ... ... a prescription,laxative product that treats acute and chronic constipation, may be ... MiraLAX(R) and generic PEG 3350 products. Marketed in the,U.S. by Cumberland ...
... for His Support of a New ... Playground, LAS ... social service agency, during a ceremonial session of,the Las Vegas City Council meeting. ... playground fundraising,efforts., Mayor Goodman was presented with a plaque of appreciation by ...
Cached Medicine News:Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 2Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 3Health News:Grupo Casa Saba Announces Fourth Quarter 2007 Results 4Health News:Nebraska's New Smoke-Free Law is Historic Win for Health 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 2Health News:World-Famous DavidBartonGym Buffs up the Bravern 3Health News:MemorialCare Sponsors Habitat for Humanity Santa Ana Home 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 2Health News:Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products 3
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions...
Disposable Cannula Cuffless Tracheostomy Tubes...
Indications For Usage: ,For use with percutaneous tracheotomies...
Medicine Products: